LncRNA Mir155hg contributes to hippocampal injury in status epilepticus rats through miR-155/Socs1/NF-κΒ signaling

Yangmei Xie1, Ming Wang2, Binyuan Xu3

  • 1Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Insights

The long non-coding RNA Mir155hg worsens neuroinflammation in status epilepticus (SE) by inhibiting the miR-155/Socs1 pathway, leading to cognitive deficits. Targeting this axis may reduce SE-induced brain injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Neuroinflammation is a key factor in cognitive impairment following status epilepticus (SE).
  • The long non-coding RNA (lncRNA) Mir155hg is implicated in inflammatory processes, but its specific role in SE pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the role of lncRNA Mir155hg in SE-induced neuroinflammation and cognitive deficits.
  • To elucidate the molecular mechanisms by which Mir155hg influences inflammatory pathways in the context of SE.

Main Methods:

  • Utilized adeno-associated virus (AAV) mediated knockdown of Mir155hg in rat models of SE.
  • Assessed cognitive function and neuronal damage using the Morris Water Maze and Nissl staining.
  • Quantified inflammatory cytokines (TNF-α, IL-1β) and NF-κB pathway activation via Western blot; explored molecular interactions using dual-luciferase assays and co-immunoprecipitation.

Main Results:

  • Elevated Mir155hg levels correlated positively with increased TNF-α and IL-1β expression in SE models.
  • Knockdown of Mir155hg significantly reduced hippocampal inflammation and NF-κB pathway activation.
  • Mir155hg functions as a competing endogenous RNA (ceRNA), sequestering miR-155 and thereby decreasing Socs1 expression, which normally targets NF-κB p65 for degradation.

Conclusions:

  • Mir155hg exacerbates SE-related neuroinflammation and cognitive deficits through the miR-155/Socs1/NF-κB signaling axis.
  • Inhibition of the Mir155hg pathway presents a potential therapeutic strategy to mitigate SE-induced neuronal injury and cognitive impairments.